Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

HYDROCODONE BITARTRATE AND ACETAMINOPHEN

ACETAMINOPHEN; HYDROCODONE BITARTRATE

Standard Dose
500MG/15ML;7.5MG/15ML
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview HYDROCODONE BITARTRATE AND ACETAMINOPHEN is listed in Drugs@FDA under application 081051 (ANDA).

Marketing status: Discontinued Active ingredient ACETAMINOPHEN; HYDROCODONE BITARTRATE Form and strength SOLUTION;ORAL - 500MG/15ML;7.5MG/15ML Sponsor MIKART Submission history Latest submission status date: 2004-01-13 00:00:00.

Structured Monograph

Clinical summary

Approval overview HYDROCODONE BITARTRATE AND ACETAMINOPHEN is listed in Drugs@FDA under application 081051 (ANDA). Marketing status: Discontinued Active ingredient ACETAMINOPHEN; HYDROCODONE BITARTRATE Form and strength SOLUTION;ORAL - 500MG/15ML;7.5MG/15ML Sponsor MIKART Submission history Latest submission status date: 2004-01-13 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.
HYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN; HYDROCODONE BITARTRATE) | Drug Monograph | MedicHelpline